IntelGenX

company

About

IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.

  • Saint Laurent,Quebec,Canada
  • 11 - 50

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$3M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2003
Number Of Employee
11 - 50
Operating Status
Active
Stock Symbol
otcqx:IGXT
Legal Name
IntelGenX Corp.
Also Known As
IntelGenx Technologies Corp.,Big Flash Corp.

IntelGenx is an oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. It provides comprehensive pharmaceutical services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP, and regulatory services. IntelGenx’s state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full-service capabilities to its clients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
10
$28.77M $9.33M
IntelGenX has raised a total of $28.77M $9.33M in funding over 2 rounds. Their latest funding was raised on Jan 9, 2023 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 9, 2023 Post-IPO Debt $3M 1 ATAI Life Sciences Detail
Feb 1, 2022 Post-IPO Debt $3M 1 ATAI Life Sciences Detail
Mar 15, 2021 Post-IPO Equity $12.34M 1 ATAI Life Sciences Detail
Mar 15, 2021 Post-IPO Debt $2M 1 ATAI Life Sciences Detail
May 8, 2018 Post-IPO Equity $3.20M Detail

Investors

Number of Lead Investors
Number of Investors
4
1
IntelGenX is funded by 1 investors. ATAI Life Sciences are the most recent investors.
Investor Name Lead Investor Funding Round
ATAI Life Sciences Yes Post-IPO Debt

Employee Profiles

Number of Employee Profiles
2
IntelGenX has 2 current employee profiles, including Executive Mark Nawacki
Executive
Executive